imatinib mesylate has been researched along with Anorexia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Acharya, MR; Goel, M; Nadkarni, S; Parray, A; Patel, S; Patkar, S; Shah, A | 1 |
| Cai, Y; Chen, X; Chen, Y; Guo, Y; Liu, C; Yang, W; Zhang, L; Zhu, X; Zou, Y | 1 |
| Fujiwara, Y; Fukuda, S; Inoue, M; Kitani, K; Ohta, Y; Tsujie, M; Wakasa, T; Yukawa, M | 1 |
3 other study(ies) available for imatinib mesylate and Anorexia
| Article | Year |
|---|---|
Primary Hepatic Gastrointestinal Stromal Tumour (GIST): Unusual Presentation and Diagnosis.
Topics: Aged; Anorexia; Chemotherapy, Adjuvant; Female; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Liver; Liver Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Weight Loss | 2020 |
Long-term safety and efficacy of imatinib in pediatric patients with chronic myeloid leukemia: single-center experience from China.
Topics: Abnormal Karyotype; Adolescent; Anorexia; Antineoplastic Agents; Child; Child, Preschool; China; Drug Evaluation; Female; Follow-Up Studies; Fusion Proteins, bcr-abl; Growth Disorders; Humans; Imatinib Mesylate; Infant; Kaplan-Meier Estimate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Male; Musculoskeletal Diseases; Progression-Free Survival; Protein Kinase Inhibitors; Remission Induction; Retrospective Studies; Treatment Outcome | 2021 |
Giant gastric gastrointestinal stromal tumor with severe peritoneal dissemination controlled by imatinib therapy following debulking surgery: a case report.
Topics: Abdominal Pain; Anorexia; Antineoplastic Agents; Combined Modality Therapy; Cytoreduction Surgical Procedures; Disease Progression; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Laparotomy; Middle Aged; Peritoneal Neoplasms; Prognosis; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2017 |